吸入コルチコステロイドの世界市場（～2026年）

• 英文タイトル：Global Inhaled Corticosteroid Market Insights and Forecast to 2026

• レポートコード：MRC2-11QY01686 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、118ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Multi User	￥865,800 (USD5,850)	▷ お問い合わせ
Enterprise License	￥1,154,400 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

当調査資料は吸入コルチコステロイドのグローバル市場について調査・分析したレポートです。種類別（ジプロピオン酸ベクロメタゾン、ブデソニド、フルチカゾン吸入器粉末、モメタゾン、その他）市場規模、用途別（病院、診療所、呼吸ケアセンター、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別吸入コルチコステロイドの競争状況、市場シェア ・世界の吸入コルチコステロイド市場：種類別市場規模 2015年-2020年（ジプロピオン酸ベクロメタゾン、ブデソニド、フルチカゾン吸入器粉末、モメタゾン、その他） ・世界の吸入コルチコステロイド市場：種類別市場規模予測 2021年-2026年（ジプロピオン酸ベクロメタゾン、ブデソニド、フルチカゾン吸入器粉末、モメタゾン、その他） ・世界の吸入コルチコステロイド市場：用途別市場規模 2015年-2020年（病院、診療所、呼吸ケアセンター、その他） ・世界の吸入コルチコステロイド市場：用途別市場規模予測 2021年-2026年（病院、診療所、呼吸ケアセンター、その他） ・北米の吸入コルチコステロイド市場分析：米国、カナダ ・ヨーロッパの吸入コルチコステロイド市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの吸入コルチコステロイド市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の吸入コルチコステロイド市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの吸入コルチコステロイド市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Sumitomo、Pfizer、Novartis、Merck、Sanofi、Johnson and Johnson、GSK、AstraZeneca、Teijin、Glaxo's Advair、Amgen、Kos Pharmaceutical、Teva Pharmaceutical ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論

Asthma is a disease of the entire respiratory tract, including large, intermediate and small airways. Asthma led to inflammation and obstruction of respiratory tract. Patients have various treatment options for asthma, particularly for young and elderly patients. Hence this has led to significant interest on the part of the inhaler device which is easy to use. Inhaled corticosteroid is the most commonly used tool for the treatment of asthma. As with increasing pollution and increasing incidences of asthma, many companies are engaged in the development of new inhaler corticosteroid devices.
In terms of market value, North America will dominate the inhaler corticosteroid device market during the forecast period. Increasing incidences of life-threatening illness such as chronic obstructive pulmonary disease, asthma and many more are some of the factors which are responsible for the growth of the market during the forecast period.

Market Analysis and Insights: Global Inhaled Corticosteroid Market
The global Inhaled Corticosteroid market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.

Global Inhaled Corticosteroid Scope and Market Size
Inhaled Corticosteroid market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Inhaled Corticosteroid market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.

Segment by Type, the Inhaled Corticosteroid market is segmented into
Beclomethasone Dipropionate
Budesonide
Fluticasone Inhaler Powder
Mometasone
Others

Segment by Application, the Inhaled Corticosteroid market is segmented into
Hospitals
Clinics
Respiratory Care Centers
Others

Regional and Country-level Analysis
The Inhaled Corticosteroid market is analysed and market size information is provided by regions (countries).
The key regions covered in the Inhaled Corticosteroid market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Inhaled Corticosteroid Market Share Analysis
Inhaled Corticosteroid market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Inhaled Corticosteroid business, the date to enter into the Inhaled Corticosteroid market, Inhaled Corticosteroid product introduction, recent developments, etc.

The major vendors covered:
Sumitomo
Pfizer
Novartis
Merck
Sanofi
Johnson and Johnson
GSK
AstraZeneca
Teijin
Glaxo’s Advair
Amgen
Kos Pharmaceutical
Teva Pharmaceutical

レポート目次

---

1 Study Coverage
1.1 Inhaled Corticosteroid Product Introduction
1.2 Market Segments
1.3 Key Inhaled Corticosteroid Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Inhaled Corticosteroid Market Size Growth Rate by Type
1.4.2 Beclomethasone Dipropionate
1.4.3 Budesonide
1.4.4 Fluticasone Inhaler Powder
1.4.5 Mometasone
1.4.6 Others
1.5 Market by Application
1.5.1 Global Inhaled Corticosteroid Market Size Growth Rate by Application
1.5.2 Hospitals
1.5.3 Clinics
1.5.4 Respiratory Care Centers
1.5.5 Others
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary
2.1 Global Inhaled Corticosteroid Market Size, Estimates and Forecasts
2.1.1 Global Inhaled Corticosteroid Revenue 2015-2026
2.1.2 Global Inhaled Corticosteroid Sales 2015-2026
2.2 Global Inhaled Corticosteroid, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Inhaled Corticosteroid Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Inhaled Corticosteroid Retrospective Market Scenario in Revenue by Region: 2015-2020

3 Global Inhaled Corticosteroid Competitor Landscape by Players
3.1 Inhaled Corticosteroid Sales by Manufacturers
3.1.1 Inhaled Corticosteroid Sales by Manufacturers (2015-2020)
3.1.2 Inhaled Corticosteroid Sales Market Share by Manufacturers (2015-2020)
3.2 Inhaled Corticosteroid Revenue by Manufacturers
3.2.1 Inhaled Corticosteroid Revenue by Manufacturers (2015-2020)
3.2.2 Inhaled Corticosteroid Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Inhaled Corticosteroid Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Inhaled Corticosteroid Revenue in 2019
3.2.5 Global Inhaled Corticosteroid Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Inhaled Corticosteroid Price by Manufacturers
3.4 Inhaled Corticosteroid Manufacturing Base Distribution, Product Types
3.4.1 Inhaled Corticosteroid Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Inhaled Corticosteroid Product Type
3.4.3 Date of International Manufacturers Enter into Inhaled Corticosteroid Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)
4.1 Global Inhaled Corticosteroid Market Size by Type (2015-2020)
4.1.1 Global Inhaled Corticosteroid Sales by Type (2015-2020)
4.1.2 Global Inhaled Corticosteroid Revenue by Type (2015-2020)
4.1.3 Inhaled Corticosteroid Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Inhaled Corticosteroid Market Size Forecast by Type (2021-2026)
4.2.1 Global Inhaled Corticosteroid Sales Forecast by Type (2021-2026)
4.2.2 Global Inhaled Corticosteroid Revenue Forecast by Type (2021-2026)
4.2.3 Inhaled Corticosteroid Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Inhaled Corticosteroid Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Market Size by Application (2015-2026)
5.1 Global Inhaled Corticosteroid Market Size by Application (2015-2020)
5.1.1 Global Inhaled Corticosteroid Sales by Application (2015-2020)
5.1.2 Global Inhaled Corticosteroid Revenue by Application (2015-2020)
5.1.3 Inhaled Corticosteroid Price by Application (2015-2020)
5.2 Inhaled Corticosteroid Market Size Forecast by Application (2021-2026)
5.2.1 Global Inhaled Corticosteroid Sales Forecast by Application (2021-2026)
5.2.2 Global Inhaled Corticosteroid Revenue Forecast by Application (2021-2026)
5.2.3 Global Inhaled Corticosteroid Price Forecast by Application (2021-2026)

6 North America
6.1 North America Inhaled Corticosteroid by Country
6.1.1 North America Inhaled Corticosteroid Sales by Country
6.1.2 North America Inhaled Corticosteroid Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Inhaled Corticosteroid Market Facts & Figures by Type
6.3 North America Inhaled Corticosteroid Market Facts & Figures by Application

7 Europe
7.1 Europe Inhaled Corticosteroid by Country
7.1.1 Europe Inhaled Corticosteroid Sales by Country
7.1.2 Europe Inhaled Corticosteroid Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Inhaled Corticosteroid Market Facts & Figures by Type
7.3 Europe Inhaled Corticosteroid Market Facts & Figures by Application

8 Asia Pacific
8.1 Asia Pacific Inhaled Corticosteroid by Region
8.1.1 Asia Pacific Inhaled Corticosteroid Sales by Region
8.1.2 Asia Pacific Inhaled Corticosteroid Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Inhaled Corticosteroid Market Facts & Figures by Type
8.3 Asia Pacific Inhaled Corticosteroid Market Facts & Figures by Application

9 Latin America
9.1 Latin America Inhaled Corticosteroid by Country
9.1.1 Latin America Inhaled Corticosteroid Sales by Country
9.1.2 Latin America Inhaled Corticosteroid Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Inhaled Corticosteroid Market Facts & Figures by Type
9.3 Central & South America Inhaled Corticosteroid Market Facts & Figures by Application

10 Middle East and Africa
10.1 Middle East and Africa Inhaled Corticosteroid by Country
10.1.1 Middle East and Africa Inhaled Corticosteroid Sales by Country
10.1.2 Middle East and Africa Inhaled Corticosteroid Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Inhaled Corticosteroid Market Facts & Figures by Type
10.3 Middle East and Africa Inhaled Corticosteroid Market Facts & Figures by Application

11 Company Profiles
11.1 Sumitomo
11.1.1 Sumitomo Corporation Information
11.1.2 Sumitomo Description and Business Overview
11.1.3 Sumitomo Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Sumitomo Inhaled Corticosteroid Products Offered
11.1.5 Sumitomo Related Developments
11.2 Pfizer
11.2.1 Pfizer Corporation Information
11.2.2 Pfizer Description and Business Overview
11.2.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Pfizer Inhaled Corticosteroid Products Offered
11.2.5 Pfizer Related Developments
11.3 Novartis
11.3.1 Novartis Corporation Information
11.3.2 Novartis Description and Business Overview
11.3.3 Novartis Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Novartis Inhaled Corticosteroid Products Offered
11.3.5 Novartis Related Developments
11.4 Merck
11.4.1 Merck Corporation Information
11.4.2 Merck Description and Business Overview
11.4.3 Merck Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Merck Inhaled Corticosteroid Products Offered
11.4.5 Merck Related Developments
11.5 Sanofi
11.5.1 Sanofi Corporation Information
11.5.2 Sanofi Description and Business Overview
11.5.3 Sanofi Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Sanofi Inhaled Corticosteroid Products Offered
11.5.5 Sanofi Related Developments
11.6 Johnson and Johnson
11.6.1 Johnson and Johnson Corporation Information
11.6.2 Johnson and Johnson Description and Business Overview
11.6.3 Johnson and Johnson Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Johnson and Johnson Inhaled Corticosteroid Products Offered
11.6.5 Johnson and Johnson Related Developments
11.7 GSK
11.7.1 GSK Corporation Information
11.7.2 GSK Description and Business Overview
11.7.3 GSK Sales, Revenue and Gross Margin (2015-2020)
11.7.4 GSK Inhaled Corticosteroid Products Offered
11.7.5 GSK Related Developments
11.8 AstraZeneca
11.8.1 AstraZeneca Corporation Information
11.8.2 AstraZeneca Description and Business Overview
11.8.3 AstraZeneca Sales, Revenue and Gross Margin (2015-2020)
11.8.4 AstraZeneca Inhaled Corticosteroid Products Offered
11.8.5 AstraZeneca Related Developments
11.9 Teijin
11.9.1 Teijin Corporation Information
11.9.2 Teijin Description and Business Overview
11.9.3 Teijin Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Teijin Inhaled Corticosteroid Products Offered
11.9.5 Teijin Related Developments
11.10 Glaxo’s Advair
11.10.1 Glaxo’s Advair Corporation Information
11.10.2 Glaxo’s Advair Description and Business Overview
11.10.3 Glaxo’s Advair Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Glaxo’s Advair Inhaled Corticosteroid Products Offered
11.10.5 Glaxo’s Advair Related Developments
11.1 Sumitomo
11.1.1 Sumitomo Corporation Information
11.1.2 Sumitomo Description and Business Overview
11.1.3 Sumitomo Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Sumitomo Inhaled Corticosteroid Products Offered
11.1.5 Sumitomo Related Developments
11.12 Kos Pharmaceutical
11.12.1 Kos Pharmaceutical Corporation Information
11.12.2 Kos Pharmaceutical Description and Business Overview
11.12.3 Kos Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
11.12.4 Kos Pharmaceutical Products Offered
11.12.5 Kos Pharmaceutical Related Developments
11.13 Teva Pharmaceutical
11.13.1 Teva Pharmaceutical Corporation Information
11.13.2 Teva Pharmaceutical Description and Business Overview
11.13.3 Teva Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
11.13.4 Teva Pharmaceutical Products Offered
11.13.5 Teva Pharmaceutical Related Developments

12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Inhaled Corticosteroid Market Estimates and Projections by Region
12.1.1 Global Inhaled Corticosteroid Sales Forecast by Regions 2021-2026
12.1.2 Global Inhaled Corticosteroid Revenue Forecast by Regions 2021-2026
12.2 North America Inhaled Corticosteroid Market Size Forecast (2021-2026)
12.2.1 North America: Inhaled Corticosteroid Sales Forecast (2021-2026)
12.2.2 North America: Inhaled Corticosteroid Revenue Forecast (2021-2026)
12.2.3 North America: Inhaled Corticosteroid Market Size Forecast by Country (2021-2026)
12.3 Europe Inhaled Corticosteroid Market Size Forecast (2021-2026)
12.3.1 Europe: Inhaled Corticosteroid Sales Forecast (2021-2026)
12.3.2 Europe: Inhaled Corticosteroid Revenue Forecast (2021-2026)
12.3.3 Europe: Inhaled Corticosteroid Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Inhaled Corticosteroid Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Inhaled Corticosteroid Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Inhaled Corticosteroid Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Inhaled Corticosteroid Market Size Forecast by Region (2021-2026)
12.5 Latin America Inhaled Corticosteroid Market Size Forecast (2021-2026)
12.5.1 Latin America: Inhaled Corticosteroid Sales Forecast (2021-2026)
12.5.2 Latin America: Inhaled Corticosteroid Revenue Forecast (2021-2026)
12.5.3 Latin America: Inhaled Corticosteroid Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Inhaled Corticosteroid Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Inhaled Corticosteroid Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Inhaled Corticosteroid Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Inhaled Corticosteroid Market Size Forecast by Country (2021-2026)

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Inhaled Corticosteroid Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Inhaled Corticosteroid Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer

List of Tables
Table 1. Inhaled Corticosteroid Market Segments
Table 2. Ranking of Global Top Inhaled Corticosteroid Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Inhaled Corticosteroid Market Size Growth Rate by Type 2020-2026 (M Units) & (US$ Million)
Table 4. Major Manufacturers of Beclomethasone Dipropionate
Table 5. Major Manufacturers of Budesonide
Table 6. Major Manufacturers of Fluticasone Inhaler Powder
Table 7. Major Manufacturers of Mometasone
Table 8. Major Manufacturers of Others
Table 9. Global Inhaled Corticosteroid Market Size Growth Rate by Application 2020-2026 (M Units)
Table 10. Global Inhaled Corticosteroid Market Size by Region (M Units) & (US$ Million): 2020 VS 2026
Table 11. Global Inhaled Corticosteroid Sales by Regions 2015-2020 (M Units)
Table 12. Global Inhaled Corticosteroid Sales Market Share by Regions (2015-2020)
Table 13. Global Inhaled Corticosteroid Revenue by Regions 2015-2020 (US$ Million)
Table 14. Global Inhaled Corticosteroid Sales by Manufacturers (2015-2020) (M Units)
Table 15. Global Inhaled Corticosteroid Sales Share by Manufacturers (2015-2020)
Table 16. Global Inhaled Corticosteroid Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 17. Global Inhaled Corticosteroid by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Inhaled Corticosteroid as of 2019)
Table 18. Inhaled Corticosteroid Revenue by Manufacturers (2015-2020) (US$ Million)
Table 19. Inhaled Corticosteroid Revenue Share by Manufacturers (2015-2020)
Table 20. Key Manufacturers Inhaled Corticosteroid Price (2015-2020) (USD/K Unit)
Table 21. Inhaled Corticosteroid Manufacturers Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Inhaled Corticosteroid Product Type
Table 23. Date of International Manufacturers Enter into Inhaled Corticosteroid Market
Table 24. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 25. Global Inhaled Corticosteroid Sales by Type (2015-2020) (M Units)
Table 26. Global Inhaled Corticosteroid Sales Share by Type (2015-2020)
Table 27. Global Inhaled Corticosteroid Revenue by Type (2015-2020) (US$ Million)
Table 28. Global Inhaled Corticosteroid Revenue Share by Type (2015-2020)
Table 29. Inhaled Corticosteroid Average Selling Price (ASP) by Type 2015-2020 (USD/K Unit)
Table 30. Global Inhaled Corticosteroid Sales by Application (2015-2020) (M Units)
Table 31. Global Inhaled Corticosteroid Sales Share by Application (2015-2020)
Table 32. North America Inhaled Corticosteroid Sales by Country (2015-2020) (M Units)
Table 33. North America Inhaled Corticosteroid Sales Market Share by Country (2015-2020)
Table 34. North America Inhaled Corticosteroid Revenue by Country (2015-2020) (US$ Million)
Table 35. North America Inhaled Corticosteroid Revenue Market Share by Country (2015-2020)
Table 36. North America Inhaled Corticosteroid Sales by Type (2015-2020) (M Units)
Table 37. North America Inhaled Corticosteroid Sales Market Share by Type (2015-2020)
Table 38. North America Inhaled Corticosteroid Sales by Application (2015-2020) (M Units)
Table 39. North America Inhaled Corticosteroid Sales Market Share by Application (2015-2020)
Table 40. Europe Inhaled Corticosteroid Sales by Country (2015-2020) (M Units)
Table 41. Europe Inhaled Corticosteroid Sales Market Share by Country (2015-2020)
Table 42. Europe Inhaled Corticosteroid Revenue by Country (2015-2020) (US$ Million)
Table 43. Europe Inhaled Corticosteroid Revenue Market Share by Country (2015-2020)
Table 44. Europe Inhaled Corticosteroid Sales by Type (2015-2020) (M Units)
Table 45. Europe Inhaled Corticosteroid Sales Market Share by Type (2015-2020)
Table 46. Europe Inhaled Corticosteroid Sales by Application (2015-2020) (M Units)
Table 47. Europe Inhaled Corticosteroid Sales Market Share by Application (2015-2020)
Table 48. Asia Pacific Inhaled Corticosteroid Sales by Region (2015-2020) (M Units)
Table 49. Asia Pacific Inhaled Corticosteroid Sales Market Share by Region (2015-2020)
Table 50. Asia Pacific Inhaled Corticosteroid Revenue by Region (2015-2020) (US$ Million)
Table 51. Asia Pacific Inhaled Corticosteroid Revenue Market Share by Region (2015-2020)
Table 52. Asia Pacific Inhaled Corticosteroid Sales by Type (2015-2020) (M Units)
Table 53. Asia Pacific Inhaled Corticosteroid Sales Market Share by Type (2015-2020)
Table 54. Asia Pacific Inhaled Corticosteroid Sales by Application (2015-2020) (M Units)
Table 55. Asia Pacific Inhaled Corticosteroid Sales Market Share by Application (2015-2020)
Table 56. Latin America Inhaled Corticosteroid Sales by Country (2015-2020) (M Units)
Table 57. Latin America Inhaled Corticosteroid Sales Market Share by Country (2015-2020)
Table 58. Latin Americaa Inhaled Corticosteroid Revenue by Country (2015-2020) (US$ Million)
Table 59. Latin America Inhaled Corticosteroid Revenue Market Share by Country (2015-2020)
Table 60. Latin America Inhaled Corticosteroid Sales by Type (2015-2020) (M Units)
Table 61. Latin America Inhaled Corticosteroid Sales Market Share by Type (2015-2020)
Table 62. Latin America Inhaled Corticosteroid Sales by Application (2015-2020) (M Units)
Table 63. Latin America Inhaled Corticosteroid Sales Market Share by Application (2015-2020)
Table 64. Middle East and Africa Inhaled Corticosteroid Sales by Country (2015-2020) (M Units)
Table 65. Middle East and Africa Inhaled Corticosteroid Sales Market Share by Country (2015-2020)
Table 66. Middle East and Africa Inhaled Corticosteroid Revenue by Country (2015-2020) (US$ Million)
Table 67. Middle East and Africa Inhaled Corticosteroid Revenue Market Share by Country (2015-2020)
Table 68. Middle East and Africa Inhaled Corticosteroid Sales by Type (2015-2020) (M Units)
Table 69. Middle East and Africa Inhaled Corticosteroid Sales Market Share by Type (2015-2020)
Table 70. Middle East and Africa Inhaled Corticosteroid Sales by Application (2015-2020) (M Units)
Table 71. Middle East and Africa Inhaled Corticosteroid Sales Market Share by Application (2015-2020)
Table 72. Sumitomo Corporation Information
Table 73. Sumitomo Description and Major Businesses
Table 74. Sumitomo Inhaled Corticosteroid Production (M Units), Revenue (US$ Million), Price (USD/K Unit) and Gross Margin (2015-2020)
Table 75. Sumitomo Product
Table 76. Sumitomo Recent Development
Table 77. Pfizer Corporation Information
Table 78. Pfizer Description and Major Businesses
Table 79. Pfizer Inhaled Corticosteroid Production (M Units), Revenue (US$ Million), Price (USD/K Unit) and Gross Margin (2015-2020)
Table 80. Pfizer Product
Table 81. Pfizer Recent Development
Table 82. Novartis Corporation Information
Table 83. Novartis Description and Major Businesses
Table 84. Novartis Inhaled Corticosteroid Production (M Units), Revenue (US$ Million), Price (USD/K Unit) and Gross Margin (2015-2020)
Table 85. Novartis Product
Table 86. Novartis Recent Development
Table 87. Merck Corporation Information
Table 88. Merck Description and Major Businesses
Table 89. Merck Inhaled Corticosteroid Production (M Units), Revenue (US$ Million), Price (USD/K Unit) and Gross Margin (2015-2020)
Table 90. Merck Product
Table 91. Merck Recent Development
Table 92. Sanofi Corporation Information
Table 93. Sanofi Description and Major Businesses
Table 94. Sanofi Inhaled Corticosteroid Production (M Units), Revenue (US$ Million), Price (USD/K Unit) and Gross Margin (2015-2020)
Table 95. Sanofi Product
Table 96. Sanofi Recent Development
Table 97. Johnson and Johnson Corporation Information
Table 98. Johnson and Johnson Description and Major Businesses
Table 99. Johnson and Johnson Inhaled Corticosteroid Production (M Units), Revenue (US$ Million), Price (USD/K Unit) and Gross Margin (2015-2020)
Table 100. Johnson and Johnson Product
Table 101. Johnson and Johnson Recent Development
Table 102. GSK Corporation Information
Table 103. GSK Description and Major Businesses
Table 104. GSK Inhaled Corticosteroid Production (M Units), Revenue (US$ Million), Price (USD/K Unit) and Gross Margin (2015-2020)
Table 105. GSK Product
Table 106. GSK Recent Development
Table 107. AstraZeneca Corporation Information
Table 108. AstraZeneca Description and Major Businesses
Table 109. AstraZeneca Inhaled Corticosteroid Production (M Units), Revenue (US$ Million), Price (USD/K Unit) and Gross Margin (2015-2020)
Table 110. AstraZeneca Product
Table 111. AstraZeneca Recent Development
Table 112. Teijin Corporation Information
Table 113. Teijin Description and Major Businesses
Table 114. Teijin Inhaled Corticosteroid Production (M Units), Revenue (US$ Million), Price (USD/K Unit) and Gross Margin (2015-2020)
Table 115. Teijin Product
Table 116. Teijin Recent Development
Table 117. Glaxo's Advair Corporation Information
Table 118. Glaxo's Advair Description and Major Businesses
Table 119. Glaxo's Advair Inhaled Corticosteroid Production (M Units), Revenue (US$ Million), Price (USD/K Unit) and Gross Margin (2015-2020)
Table 120. Glaxo's Advair Product
Table 121. Glaxo's Advair Recent Development
Table 122. Amgen Corporation Information
Table 123. Amgen Description and Major Businesses
Table 124. Amgen Inhaled Corticosteroid Sales (M Units), Revenue (US$ Million), Price (USD/K Unit) and Gross Margin (2015-2020)
Table 125. Amgen Product
Table 126. Amgen Recent Development
Table 127. Kos Pharmaceutical Corporation Information
Table 128. Kos Pharmaceutical Description and Major Businesses
Table 129. Kos Pharmaceutical Inhaled Corticosteroid Sales (M Units), Revenue (US$ Million), Price (USD/K Unit) and Gross Margin (2015-2020)
Table 130. Kos Pharmaceutical Product
Table 131. Kos Pharmaceutical Recent Development
Table 132. Teva Pharmaceutical Corporation Information
Table 133. Teva Pharmaceutical Description and Major Businesses
Table 134. Teva Pharmaceutical Inhaled Corticosteroid Sales (M Units), Revenue (US$ Million), Price (USD/K Unit) and Gross Margin (2015-2020)
Table 135. Teva Pharmaceutical Product
Table 136. Teva Pharmaceutical Recent Development
Table 137. Global Inhaled Corticosteroid Sales Forecast by Regions (2021-2026) (M Units)
Table 138. Global Inhaled Corticosteroid Sales Market Share Forecast by Regions (2021-2026)
Table 139. Global Inhaled Corticosteroid Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 140. Global Inhaled Corticosteroid Revenue Market Share Forecast by Regions (2021-2026)
Table 141. North America: Inhaled Corticosteroid Sales Forecast by Country (2021-2026) (M Units)
Table 142. North America: Inhaled Corticosteroid Revenue Forecast by Country (2021-2026) (US$ Million)
Table 143. Europe: Inhaled Corticosteroid Sales Forecast by Country (2021-2026) (M Units)
Table 144. Europe: Inhaled Corticosteroid Revenue Forecast by Country (2021-2026) (US$ Million)
Table 145. Asia Pacific: Inhaled Corticosteroid Sales Forecast by Region (2021-2026) (M Units)
Table 146. Asia Pacific: Inhaled Corticosteroid Revenue Forecast by Region (2021-2026) (US$ Million)
Table 147. Latin America: Inhaled Corticosteroid Sales Forecast by Country (2021-2026) (M Units)
Table 148. Latin America: Inhaled Corticosteroid Revenue Forecast by Country (2021-2026) (US$ Million)
Table 149. Middle East and Africa: Inhaled Corticosteroid Sales Forecast by Country (2021-2026) (M Units)
Table 150. Middle East and Africa: Inhaled Corticosteroid Revenue Forecast by Country (2021-2026) (US$ Million)
Table 151. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 152. Key Challenges
Table 153. Market Risks
Table 154. Main Points Interviewed from Key Inhaled Corticosteroid Players
Table 155. Inhaled Corticosteroid Customers List
Table 156. Inhaled Corticosteroid Distributors List
Table 157. Research Programs/Design for This Report
Table 158. Key Data Information from Secondary Sources
Table 159. Key Data Information from Primary Sources
List of Figures
Figure 1. Inhaled Corticosteroid Product Picture
Figure 2. Global Inhaled Corticosteroid Sales Market Share by Type in 2020 & 2026
Figure 3. Beclomethasone Dipropionate Product Picture
Figure 4. Budesonide Product Picture
Figure 5. Fluticasone Inhaler Powder Product Picture
Figure 6. Mometasone Product Picture
Figure 7. Others Product Picture
Figure 8. Global Inhaled Corticosteroid Sales Market Share by Application in 2020 & 2026
Figure 9. Hospitals
Figure 10. Clinics
Figure 11. Respiratory Care Centers
Figure 12. Others
Figure 13. Inhaled Corticosteroid Report Years Considered
Figure 14. Global Inhaled Corticosteroid Market Size 2015-2026 (US$ Million)
Figure 15. Global Inhaled Corticosteroid Sales 2015-2026 (M Units)
Figure 16. Global Inhaled Corticosteroid Market Size Market Share by Region: 2020 Versus 2026
Figure 17. Global Inhaled Corticosteroid Sales Market Share by Region (2015-2020)
Figure 18. Global Inhaled Corticosteroid Sales Market Share by Region in 2019
Figure 19. Global Inhaled Corticosteroid Revenue Market Share by Region (2015-2020)
Figure 20. Global Inhaled Corticosteroid Revenue Market Share by Region in 2019
Figure 21. Global Inhaled Corticosteroid Sales Share by Manufacturer in 2019
Figure 22. The Top 10 and 5 Players Market Share by Inhaled Corticosteroid Revenue in 2019
Figure 23. Inhaled Corticosteroid Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 24. Global Inhaled Corticosteroid Sales Market Share by Type (2015-2020)
Figure 25. Global Inhaled Corticosteroid Sales Market Share by Type in 2019
Figure 26. Global Inhaled Corticosteroid Revenue Market Share by Type (2015-2020)
Figure 27. Global Inhaled Corticosteroid Revenue Market Share by Type in 2019
Figure 28. Global Inhaled Corticosteroid Market Share by Price Range (2015-2020)
Figure 29. Global Inhaled Corticosteroid Sales Market Share by Application (2015-2020)
Figure 30. Global Inhaled Corticosteroid Sales Market Share by Application in 2019
Figure 31. Global Inhaled Corticosteroid Revenue Market Share by Application (2015-2020)
Figure 32. Global Inhaled Corticosteroid Revenue Market Share by Application in 2019
Figure 33. North America Inhaled Corticosteroid Sales Growth Rate 2015-2020 (M Units)
Figure 34. North America Inhaled Corticosteroid Revenue Growth Rate 2015-2020 (US$ Million)
Figure 35. North America Inhaled Corticosteroid Sales Market Share by Country in 2019
Figure 36. North America Inhaled Corticosteroid Revenue Market Share by Country in 2019
Figure 37. U.S. Inhaled Corticosteroid Sales Growth Rate (2015-2020) (M Units)
Figure 38. U.S. Inhaled Corticosteroid Revenue Growth Rate (2015-2020) (US$ Million)
Figure 39. Canada Inhaled Corticosteroid Sales Growth Rate (2015-2020) (M Units)
Figure 40. Canada Inhaled Corticosteroid Revenue Growth Rate (2015-2020) (US$ Million)
Figure 41. North America Inhaled Corticosteroid Market Share by Type in 2019
Figure 42. North America Inhaled Corticosteroid Market Share by Application in 2019
Figure 43. Europe Inhaled Corticosteroid Sales Growth Rate 2015-2020 (M Units)
Figure 44. Europe Inhaled Corticosteroid Revenue Growth Rate 2015-2020 (US$ Million)
Figure 45. Europe Inhaled Corticosteroid Sales Market Share by Country in 2019
Figure 46. Europe Inhaled Corticosteroid Revenue Market Share by Country in 2019
Figure 47. Germany Inhaled Corticosteroid Sales Growth Rate (2015-2020) (M Units)
Figure 48. Germany Inhaled Corticosteroid Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. France Inhaled Corticosteroid Sales Growth Rate (2015-2020) (M Units)
Figure 50. France Inhaled Corticosteroid Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. U.K. Inhaled Corticosteroid Sales Growth Rate (2015-2020) (M Units)
Figure 52. U.K. Inhaled Corticosteroid Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Italy Inhaled Corticosteroid Sales Growth Rate (2015-2020) (M Units)
Figure 54. Italy Inhaled Corticosteroid Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. Russia Inhaled Corticosteroid Sales Growth Rate (2015-2020) (M Units)
Figure 56. Russia Inhaled Corticosteroid Revenue Growth Rate (2015-2020) (US$ Million)
Figure 57. Europe Inhaled Corticosteroid Market Share by Type in 2019
Figure 58. Europe Inhaled Corticosteroid Market Share by Application in 2019
Figure 59. Asia Pacific Inhaled Corticosteroid Sales Growth Rate 2015-2020 (M Units)
Figure 60. Asia Pacific Inhaled Corticosteroid Revenue Growth Rate 2015-2020 (US$ Million)
Figure 61. Asia Pacific Inhaled Corticosteroid Sales Market Share by Region in 2019
Figure 62. Asia Pacific Inhaled Corticosteroid Revenue Market Share by Region in 2019
Figure 63. China Inhaled Corticosteroid Sales Growth Rate (2015-2020) (M Units)
Figure 64. China Inhaled Corticosteroid Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. Japan Inhaled Corticosteroid Sales Growth Rate (2015-2020) (M Units)
Figure 66. Japan Inhaled Corticosteroid Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. South Korea Inhaled Corticosteroid Sales Growth Rate (2015-2020) (M Units)
Figure 68. South Korea Inhaled Corticosteroid Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. India Inhaled Corticosteroid Sales Growth Rate (2015-2020) (M Units)
Figure 70. India Inhaled Corticosteroid Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Australia Inhaled Corticosteroid Sales Growth Rate (2015-2020) (M Units)
Figure 72. Australia Inhaled Corticosteroid Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Taiwan Inhaled Corticosteroid Sales Growth Rate (2015-2020) (M Units)
Figure 74. Taiwan Inhaled Corticosteroid Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Indonesia Inhaled Corticosteroid Sales Growth Rate (2015-2020) (M Units)
Figure 76. Indonesia Inhaled Corticosteroid Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Thailand Inhaled Corticosteroid Sales Growth Rate (2015-2020) (M Units)
Figure 78. Thailand Inhaled Corticosteroid Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Malaysia Inhaled Corticosteroid Sales Growth Rate (2015-2020) (M Units)
Figure 80. Malaysia Inhaled Corticosteroid Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Philippines Inhaled Corticosteroid Sales Growth Rate (2015-2020) (M Units)
Figure 82. Philippines Inhaled Corticosteroid Revenue Growth Rate (2015-2020) (US$ Million)
Figure 83. Vietnam Inhaled Corticosteroid Sales Growth Rate (2015-2020) (M Units)
Figure 84. Vietnam Inhaled Corticosteroid Revenue Growth Rate (2015-2020) (US$ Million)
Figure 85. Asia Pacific Inhaled Corticosteroid Market Share by Type in 2019
Figure 86. Asia Pacific Inhaled Corticosteroid Market Share by Application in 2019
Figure 87. Latin America Inhaled Corticosteroid Sales Growth Rate 2015-2020 (M Units)
Figure 88. Latin America Inhaled Corticosteroid Revenue Growth Rate 2015-2020 (US$ Million)
Figure 89. Latin America Inhaled Corticosteroid Sales Market Share by Country in 2019
Figure 90. Latin America Inhaled Corticosteroid Revenue Market Share by Country in 2019
Figure 91. Mexico Inhaled Corticosteroid Sales Growth Rate (2015-2020) (M Units)
Figure 92. Mexico Inhaled Corticosteroid Revenue Growth Rate (2015-2020) (US$ Million)
Figure 93. Brazil Inhaled Corticosteroid Sales Growth Rate (2015-2020) (M Units)
Figure 94. Brazil Inhaled Corticosteroid Revenue Growth Rate (2015-2020) (US$ Million)
Figure 95. Argentina Inhaled Corticosteroid Sales Growth Rate (2015-2020) (M Units)
Figure 96. Argentina Inhaled Corticosteroid Revenue Growth Rate (2015-2020) (US$ Million)
Figure 97. Latin America Inhaled Corticosteroid Market Share by Type in 2019
Figure 98. Latin America Inhaled Corticosteroid Market Share by Application in 2019
Figure 99. Middle East and Africa Inhaled Corticosteroid Sales Growth Rate 2015-2020 (M Units)
Figure 100. Middle East and Africa Inhaled Corticosteroid Revenue Growth Rate 2015-2020 (US$ Million)
Figure 101. Middle East and Africa Inhaled Corticosteroid Sales Market Share by Country in 2019
Figure 102. Middle East and Africa Inhaled Corticosteroid Revenue Market Share by Country in 2019
Figure 103. Turkey Inhaled Corticosteroid Sales Growth Rate (2015-2020) (M Units)
Figure 104. Turkey Inhaled Corticosteroid Revenue Growth Rate (2015-2020) (US$ Million)
Figure 105. Saudi Arabia Inhaled Corticosteroid Sales Growth Rate (2015-2020) (M Units)
Figure 106. Saudi Arabia Inhaled Corticosteroid Revenue Growth Rate (2015-2020) (US$ Million)
Figure 107. U.A.E Inhaled Corticosteroid Sales Growth Rate (2015-2020) (M Units)
Figure 108. U.A.E Inhaled Corticosteroid Revenue Growth Rate (2015-2020) (US$ Million)
Figure 109. Middle East and Africa Inhaled Corticosteroid Market Share by Type in 2019
Figure 110. Middle East and Africa Inhaled Corticosteroid Market Share by Application in 2019
Figure 111. North America Inhaled Corticosteroid Sales Growth Rate Forecast (2021-2026) (M Units)
Figure 112. North America Inhaled Corticosteroid Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 113. Europe Inhaled Corticosteroid Sales Growth Rate Forecast (2021-2026) (M Units)
Figure 114. Europe Inhaled Corticosteroid Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 115. Asia Pacific Inhaled Corticosteroid Sales Growth Rate Forecast (2021-2026) (M Units)
Figure 116. Asia Pacific Inhaled Corticosteroid Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 117. Latin America Inhaled Corticosteroid Sales Growth Rate Forecast (2021-2026) (M Units)
Figure 118. Latin America Inhaled Corticosteroid Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 119. Middle East and Africa Inhaled Corticosteroid Sales Growth Rate Forecast (2021-2026) (M Units)
Figure 120. Middle East and Africa Inhaled Corticosteroid Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 121. Porter's Five Forces Analysis
Figure 122. Channels of Distribution
Figure 123. Distributors Profiles
Figure 124. Bottom-up and Top-down Approaches for This Report
Figure 125. Data Triangulation
Figure 126. Key Executives Interviewed

---